D-Attachment-Submission Instructions.pdf
PDF 468 KB Posted
- Solicitation number
- 75N95022Q00098
About this file
This document summarizes a solicitation for a commercial item contract to generate Alzheimer's disease and related dementia patient-derived induced pluripotent stem cell lines. The National Institutes of Health National Institute on Drug Abuse is seeking up to 200 engineered iPSC lines derived from human patient fresh whole blood or peripheral blood mononuclear cells. The anticipated period of performance is one base year from July 1, 2022 to June 30, 2023 with an option to extend for one additional year. Offerors must provide past experience generating biobanks of iPSC lines, pricing for the base and option years, and technical and price proposals by the response deadline of April 14, 2022. The award will be a firm fixed-price purchase order made to the responsible offeror whose proposal represents the best value based on technical capability, past performance, and price factors.
View the file
Other files
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Submission Instructions
Solicitation 75N95022Q00098
Past performance: Offerors shall provide examples of the following:
1. Past similar efforts in generating biobanks of iPSC lines using these methods.
Price: Offerors shall provide prices for the base and option year, as described below:
Total Base Year $ Option Year 1 $ Total $
File details come from the government source that posted it. Updated .